| Ms Karen Trister Grace, CNM | |
|
8908 Riggs Rd, Adelphi, MD 20783-1632 | |
| (301) 422-5900 | |
| Not Available |
| Full Name | Ms Karen Trister Grace |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 8908 Riggs Rd, Adelphi, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174612733 | NPI | - | NPPES |
| 02192703 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | R198508 (Maryland) | Primary |
| 176B00000X | Midwife | 000990 (New York) | Secondary |
| Entity Name | Marys Center For Maternal And Child Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962520288 PECOS PAC ID: 5092798298 Enrollment ID: O20040609000873 |
News Archive
A rare mutation in the gene encoding the triggering receptor expressed on myeloid cells 2 has a potent effect on the risk for late-onset Alzheimer's disease, two studies published in The New England Journal of Medicine suggest.
"This is perhaps the first time that it has been demonstrated that HIV positive children can be successfully treated with antiretroviral therapy in resource-limited settings and the outcomes are comparable to those we have seen in U.S. pediatric antiretroviral clinical trials,"
Enabling clinicians to seamlessly transition between cardiac and peripheral intervention during a single procedure, Infinix DP-i cardiovascular X-ray system from Toshiba America Medical Systems, Inc. will be used in eight live cases at Peripheral Angioplasty and All That Jazz conference, Oct. 31 - Nov. 2, 2011, New Orleans.
A new study conducted at the Hamot Medical Center in Erie, Pennsylvania, and published by Elsevier in the February 2009 issue of The Journal of Emergency Medicine shows that there is a lack of education and understanding in what sets a living will in motion in a pre-hospital setting. Education and implementation of code status designations can clarify this confusion.
Urovalve, a medical device company focused on creating superior products for urinary flow and control, announced today that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for the Company's Surinate® Bladder Management System, allowing Urovalve to conduct a clinical study for the Company's lead device in the United States.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Karen Trister Grace, CNM 5309 Wehawken Rd, Bethesda, MD 20816-3137 Ph: (347) 742-8108 | Ms Karen Trister Grace, CNM 8908 Riggs Rd, Adelphi, MD 20783-1632 Ph: (301) 422-5900 |
News Archive
A rare mutation in the gene encoding the triggering receptor expressed on myeloid cells 2 has a potent effect on the risk for late-onset Alzheimer's disease, two studies published in The New England Journal of Medicine suggest.
"This is perhaps the first time that it has been demonstrated that HIV positive children can be successfully treated with antiretroviral therapy in resource-limited settings and the outcomes are comparable to those we have seen in U.S. pediatric antiretroviral clinical trials,"
Enabling clinicians to seamlessly transition between cardiac and peripheral intervention during a single procedure, Infinix DP-i cardiovascular X-ray system from Toshiba America Medical Systems, Inc. will be used in eight live cases at Peripheral Angioplasty and All That Jazz conference, Oct. 31 - Nov. 2, 2011, New Orleans.
A new study conducted at the Hamot Medical Center in Erie, Pennsylvania, and published by Elsevier in the February 2009 issue of The Journal of Emergency Medicine shows that there is a lack of education and understanding in what sets a living will in motion in a pre-hospital setting. Education and implementation of code status designations can clarify this confusion.
Urovalve, a medical device company focused on creating superior products for urinary flow and control, announced today that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for the Company's Surinate® Bladder Management System, allowing Urovalve to conduct a clinical study for the Company's lead device in the United States.
› Verified 9 days ago